“…Several flavonoids activate eNOS in a Ca 2+ -independent manner through the induction of Ser-1179 phosphorylation and/or Thr-495 dephosphorylation [e.g., epigallocatechin gallate (39), quercetin (40), luteolin (41), hesperetin (42), hesperidin and naringin (43)] or through a Ca 2+dependent mechanism [e.g., quercetin (44) and (-)-epicatechin (45)]. Furthermore, flavonoids down-regulate caveloin-1 (a negative regulator of eNOS) expression or dissociate it from eNOS (45,46), activate the chaperone protein HSP90 that is involved in eNOS activation (47), reduce the level of the eNOS inhibitor asymmetrical dimethylarginine (48,49), or inhibit arginase to increase the level of the eNOS substrate arginine (50,51), thus stimulating eNOS activity, and enhancing NO production. Moreover, quercetin, naringenin, and fisetin activate sirtuin-1 that, in turn, deacetylates eNOS, thus improving endothelial function (52).…”